BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Triggle CR, Bansal D, Ding H, Islam MM, Farag EABA, Hadi HA, Sultan AA. A Comprehensive Review of Viral Characteristics, Transmission, Pathophysiology, Immune Response, and Management of SARS-CoV-2 and COVID-19 as a Basis for Controlling the Pandemic. Front Immunol 2021;12:631139. [PMID: 33717166 DOI: 10.3389/fimmu.2021.631139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Amblard F, Lecher JC, De R, Goh SL, Li C, Kasthuri M, Biteau N, Zhou L, Tber Z, Downs-bowen J, Zandi K, Schinazi RF. Synthesis of Novel N4-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents. Pharmaceuticals 2022;15:1144. [DOI: 10.3390/ph15091144] [Reference Citation Analysis]
2 Liapis I, Baritaki S. COVID-19 vs. Cancer Immunosurveillance: A Game of Thrones within an Inflamed Microenviroment. Cancers (Basel) 2022;14:4330. [PMID: 36077865 DOI: 10.3390/cancers14174330] [Reference Citation Analysis]
3 Huang JR, Shen HC, Sun CY, Chen WC, Chen YM, Feng JY, Yang KY. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding. J Formos Med Assoc 2022:S0929-6646(22)00279-0. [PMID: 35953342 DOI: 10.1016/j.jfma.2022.07.006] [Reference Citation Analysis]
4 Jagroop-Dearing A, Leonard G, Shahid SM, van Dulm O. COVID-19 Lockdown in New Zealand: Perceived Stress and Wellbeing among International Health Students Who Were Essential Frontline Workers. Int J Environ Res Public Health 2022;19:9688. [PMID: 35955044 DOI: 10.3390/ijerph19159688] [Reference Citation Analysis]
5 Sapir T, Averch Z, Lerman B, Bodzin A, Fishman Y, Maitra R. COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19. IJMS 2022;23:8606. [DOI: 10.3390/ijms23158606] [Reference Citation Analysis]
6 Khawaja F, Srinivasan K, Spallone A, Feldman A, Cantu S, Ariza-Heredia E, Dvordak T, Alousi A, Ahmed S, George M, Frenzel E, Bhatti M, Chemaly RF. Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: lessons learned. Am J Infect Control 2022:S0196-6553(22)00575-2. [PMID: 35901993 DOI: 10.1016/j.ajic.2022.07.019] [Reference Citation Analysis]
7 Hoteit R, Yassine HM. Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences. Vaccines (Basel) 2022;10:919. [PMID: 35746526 DOI: 10.3390/vaccines10060919] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
8 Aswad M, Hamza H, Pechkovsky A, Zikrach A, Popov T, Zohar Y, Shahar E, Louria-Hayon I. High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs. Front Immunol 2022;13:875546. [PMID: 35651623 DOI: 10.3389/fimmu.2022.875546] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kheiroddin P, Gaertner VD, Schöberl P, Fischer E, Niggel J, Pagel P, Lampl BMJ, Ambrosch A, Kabesch M. Gargle Pool PCR Testing in a Hospital during medium and high SARS-CoV-2 incidence. J Hosp Infect 2022:S0195-6701(22)00182-7. [PMID: 35671860 DOI: 10.1016/j.jhin.2022.05.018] [Reference Citation Analysis]
10 Petersen DC, Steyl C, Scholtz D, Baker B, Abdullah I, Uren C, Möller M; and for The COVID-19 Host Genetics Project. African Genetic Representation in the Context of SARS-CoV-2 Infection and COVID-19 Severity. Front Genet 2022;13:909117. [PMID: 35620464 DOI: 10.3389/fgene.2022.909117] [Reference Citation Analysis]
11 Society for Adolescent Health and Medicine. COVID Vaccines in Adolescents and Young Adults. J Adolesc Health 2022;70:1002-5. [PMID: 35597558 DOI: 10.1016/j.jadohealth.2022.03.009] [Reference Citation Analysis]
12 Carmagnola D, Toma M, Henin D, Perrotta M, Pellegrini G, Dellavia C. Personal Protection Equipment and Infection Control Procedures among Health Workers during the COVID-19 Pandemic. Healthcare 2022;10:944. [DOI: 10.3390/healthcare10050944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dumache R, Enache A, Macasoi I, Dehelean CA, Dumitrascu V, Mihailescu A, Popescu R, Vlad D, Vlad CS, Muresan C. SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern. Pathogens 2022;11:516. [DOI: 10.3390/pathogens11050516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Adelmeyer J, Goebel JN, Kauka A, Kann PH, Frindik JP. Two Case Reports of Subacute Thyroiditis after Receiving Vaccine for COVID-19. Case Reports in Endocrinology 2022;2022:1-9. [DOI: 10.1155/2022/3180004] [Reference Citation Analysis]
15 Beeraka NM, Sukocheva OA, Lukina E, Liu J, Fan R. Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines. Rev Med Virol 2022;:e2346. [PMID: 35416390 DOI: 10.1002/rmv.2346] [Reference Citation Analysis]
16 Miller EW, Lamberson CM, Akabari RR, Riddell SW, Middleton FA, Nasr MR, Smith SC, Sperber SM. Development and Validation of Two RT-qPCR Diagnostic Assays for Detecting Severe Acute Respiratory Syndrome Coronavirus 2 Genomic Targets across Two Specimen Types. J Mol Diagn 2022;24:294-308. [PMID: 35124239 DOI: 10.1016/j.jmoldx.2021.12.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gomez Marti JL, Mays A, McCullough M, Wells A, Phan T. Evaluation of Viral Loads in Patients With SARS-CoV-2 Delta Variant Infection: Higher Loads Do Not Translate Into Different Testing Scenarios. Microbiol Insights 2022;15:11786361221087537. [PMID: 35341107 DOI: 10.1177/11786361221087537] [Reference Citation Analysis]
18 Taşlı NP, Gönen ZB, Kırbaş OK, Gökdemir NS, Bozkurt BT, Bayrakcı B, Sağraç D, Taşkan E, Demir S, Ekimci Gürcan N, Bayındır Bilgiç M, Bayrak ÖF, Yetişkin H, Kaplan B, Pavel STI, Dinç G, Serhatlı M, Çakırca G, Eken A, Aslan V, Yay M, Karakukcu M, Unal E, Gül F, Basaran KE, Ozkul Y, Şahin F, Jones OY, Tekin Ş, Özdarendeli A, Cetin M. Preclinical Studies on Convalescent Human Immune Plasma-Derived Exosome: Omics and Antiviral Properties to SARS-CoV-2. Front Immunol 2022;13:824378. [DOI: 10.3389/fimmu.2022.824378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Carmagnola D, Toma M, Henin D, Perrotta M, Gianolio L, Colombo A, Dellavia C. Dental Emergencies in an Italian Pediatric Hospital during the COVID-19 Pandemic. Healthcare 2022;10:537. [DOI: 10.3390/healthcare10030537] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kebria MM, Milan PB, Peyravian N, Kiani J, Khatibi S, Mozafari M. Stem cell therapy for COVID-19 pneumonia. Mol Biomed 2022;3:6. [PMID: 35174448 DOI: 10.1186/s43556-021-00067-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Favero R, Hajrulla S, Bordin A, Mucignat-Caretta C, Gaudioso P, Scarpa B, Favero L, Ottaviano G. Olfactory Dysfunction in COVID-19 Patients Who Do Not Report Olfactory Symptoms: A Pilot Study with Some Suggestions for Dentists. Int J Environ Res Public Health 2022;19:1036. [PMID: 35162061 DOI: 10.3390/ijerph19031036] [Reference Citation Analysis]
22 Lopes LR, Kasinski SK. The potential impact of COVID-19 and diabetes on intervertebral disc degeneration. Einstein (Sao Paulo) 2022;19:eCE6911. [PMID: 35019039 DOI: 10.31744/einstein_journal/2021CE6911] [Reference Citation Analysis]
23 Zhang M, Liang Y, Yu D, Du B, Cheng W, Li L, Yu Z, Luo S, Zhang Y, Wang H, Zhang X, Zhang W. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Int J Biol Sci 2022;18:889-900. [PMID: 35002532 DOI: 10.7150/ijbs.68973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
24 Di Sarno V, Lauro G, Musella S, Ciaglia T, Vestuto V, Sala M, Scala MC, Smaldone G, Di Matteo F, Novi S, Tecce MF, Moltedo O, Bifulco G, Campiglia P, Gomez-Monterrey IM, Snoeck R, Andrei G, Ostacolo C, Bertamino A. Identification of a dual acting SARS-CoV-2 proteases inhibitor through in silico design and step-by-step biological characterization. Eur J Med Chem 2021;226:113863. [PMID: 34571172 DOI: 10.1016/j.ejmech.2021.113863] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Wang Y, Tang CY, Wan XF. Antigenic characterization of influenza and SARS-CoV-2 viruses. Anal Bioanal Chem 2021. [PMID: 34905077 DOI: 10.1007/s00216-021-03806-6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Soltani Hekmat A, Javanmardi K. Alamandine: Potential Protective Effects in SARS-CoV-2 Patients. J Renin Angiotensin Aldosterone Syst 2021;2021:6824259. [PMID: 34853605 DOI: 10.1155/2021/6824259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Barnby E, Reynolds M, Gordon J. Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know. NASN Sch Nurse 2022;37:13-8. [PMID: 34836470 DOI: 10.1177/1942602X211044996] [Reference Citation Analysis]
28 Brasen CL, Christensen H, Olsen DA, Kahns S, Andersen RF, Madsen JB, Lassen A, Kierkegaard H, Jensen A, Sydenham TV, Madsen JS, Møller JK, Brandslund I. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19. Clin Chem Lab Med 2021;59:1988-97. [PMID: 34455731 DOI: 10.1515/cclm-2021-0694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Reference Citation Analysis]
30 Antonucci F, Fiore JR, De Feo L, Granato T, Di Stefano M, Faleo G, Farhan AM, Margaglione M, Centra M, Santantonio TA. Increased SARS-CoV-2 seroprevalence in healthy blood donors after the second pandemic wave in South-Eastern Italy: evidence for asymptomatic young donors as potential virus spreaders. Infect Dis (Lond) 2021;:1-6. [PMID: 34781812 DOI: 10.1080/23744235.2021.2003856] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Pedler RL, Speck PG. Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals. Rev Med Virol 2021;:e2310. [PMID: 34726308 DOI: 10.1002/rmv.2310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Sfikakis PP, Verrou KM, Ampatziadis-Michailidis G, Tsitsilonis O, Paraskevis D, Kastritis E, Lianidou E, Moutsatsou P, Terpos E, Trougakos I, Chini V, Manoloukos M, Moulos P, Pavlopoulos GA, Kollias G, Hatzis P, Dimopoulos MA. Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection. Front Immunol 2021;12:746203. [PMID: 34675930 DOI: 10.3389/fimmu.2021.746203] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
33 Bonato M, Fraccaro A, Landini N, Zanardi G, Catino C, Savoia F, Malacchini N, Zeraj F, Peditto P, Catalanotti V, Marcon E, Rossi E, Pauletti A, Galvan S, Adami R, Tiepolo M, Salasnich M, Cuzzola M, Zampieri F, Rattazzi M, Peta M, Baraldo S, Saetta M, Morana G, Romagnoli M. Pneumothorax and/or Pneumomediastinum Worsens the Prognosis of COVID-19 Patients with Severe Acute Respiratory Failure: A Multicenter Retrospective Case-Control Study in the North-East of Italy. J Clin Med 2021;10:4835. [PMID: 34768352 DOI: 10.3390/jcm10214835] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Storek J, Kanji JN, Choi M, Kalra A, Chaudhry A, Jamani K, Dharmani-Khan P, Khan FM. Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody response. Bone Marrow Transplant 2021. [PMID: 34616007 DOI: 10.1038/s41409-021-01489-2] [Reference Citation Analysis]
35 Ozdemir A, Kocak SY, Karabela SN, Yılmaz M. [Can systemic immune inflammation index at admission predict in-hospital mortality in chronic kidney disease patients with SARS-CoV-2 infection]. Nefrologia (Engl Ed) 2021. [PMID: 34539001 DOI: 10.1016/j.nefro.2021.09.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Bahadur Gurung A, Ajmal Ali M, Lee J, Abul Farah M, Mashay Al-Anazi K, Al-Hemaid F. Identification of SARS-CoV-2 inhibitors from extracts of Houttuynia cordata Thunb. Saudi J Biol Sci 2021;28:7517-27. [PMID: 34512097 DOI: 10.1016/j.sjbs.2021.08.100] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
37 Irvine NJ, Wiles BL. Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus 2021;13:e16858. [PMID: 34513435 DOI: 10.7759/cureus.16858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Danics K, Pesti A, Törő K, Kiss-Dala N, Szlávik J, Lakatos B, Radnai A, Balázs T, Bacskai M, Dobi D, Várkonyi T, Glasz T, Lotz G, Kiss A, Schaff Z, Vályi-Nagy I. A COVID-19-association-dependent categorization of death causes in 100 autopsy cases. Geroscience 2021;43:2265-87. [PMID: 34510338 DOI: 10.1007/s11357-021-00451-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Mura C, Preissner S, Preissner R, Bourne PE. A Birds-Eye (Re)View of Acid-Suppression Drugs, COVID-19, and the Highly Variable Literature. Front Pharmacol 2021;12:700703. [PMID: 34456726 DOI: 10.3389/fphar.2021.700703] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
40 Popova AY, Smirnov VS, Andreeva EE, Babura EA, Balakhonov SV, Bashketova NS, Bugorkova SA, Bulanov MV, Valeullina NN, Vetrov VV, Goryaev DV, Detkovskaya TN, Ezhlova EB, Zaitseva NN, Istorik OA, Kovalchuk IV, Kozlovskikh DN, Kombarova SY, Kurganova OP, Lomovtsev AE, Lukicheva LA, Lyalina LV, Melnikova AA, Mikailova OM, Noskov AK, Noskova LN, Oglezneva EE, Osmolovskaya TP, Patyashina MA, Penkovskaya NA, Samoilova LV, Stepanova TF, Trotsenko OE, Totolian AA. SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic. Viruses 2021;13:1648. [PMID: 34452512 DOI: 10.3390/v13081648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
41 Singh VK, Chaurasia H, Kumari P, Som A, Mishra R, Srivastava R, Naaz F, Singh A, Singh RK. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2. J Biomol Struct Dyn 2021;:1-24. [PMID: 34253149 DOI: 10.1080/07391102.2021.1946716] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
42 Graalmann T, Borst K, Manchanda H, Vaas L, Bruhn M, Graalmann L, Koster M, Verboom M, Hallensleben M, Guzmán CA, Sutter G, Schmidt RE, Witte T, Kalinke U. B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner. Ann Rheum Dis 2021:annrheumdis-2021-220435. [PMID: 34226189 DOI: 10.1136/annrheumdis-2021-220435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
43 Chen HH, Kao JH, Chen JS, Ni YH. What we have learned from COVID-19 pandemic? J Formos Med Assoc 2021;120 Suppl 1:S1-5. [PMID: 34167668 DOI: 10.1016/j.jfma.2021.06.005] [Reference Citation Analysis]
44 Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, Singh M, Lievano F, Tafur A, Ramacciotti E, Gerotziafas GT, Jeske W, Fareed J. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost 2021;27:10760296211021498. [PMID: 34060379 DOI: 10.1177/10760296211021498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
45 Shahani P, Datta I. Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much? Cytotherapy 2021:S1465-3249(21)00234-6. [PMID: 34053857 DOI: 10.1016/j.jcyt.2021.04.004] [Cited by in F6Publishing: 3] [Reference Citation Analysis]